4-(Methylcarbamoyl)benzoic acid is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a key role in the development of drugs targeting specific therapeutic areas, such as anti-inflammatory and analgesic medications. Additionally, it is employed in organic synthesis to create compounds with potential biological activity, aiding in drug discovery and research. Its structural properties make it a valuable building block for designing molecules with enhanced efficacy and specificity in medical applications.